Xiong Liu Selected Research

Induction Chemotherapy

5/2021	Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
4/2018	A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiong Liu Research Topics

Disease

48	Neoplasms (Cancer) 11/2024 - 05/2004
37	Nasopharyngeal Carcinoma 12/2023 - 03/2004
28	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2004
10	Body Weight (Weight, Body) 01/2024 - 02/2009
10	Infections 06/2023 - 06/2009
7	Breast Neoplasms (Breast Cancer) 11/2023 - 11/2018
5	Carcinogenesis 01/2023 - 04/2013
5	COVID-19 11/2022 - 01/2020
4	Laryngopharyngeal Reflux 11/2020 - 02/2009
4	Lymphatic Metastasis 04/2018 - 05/2004
3	Ulcerative Colitis 01/2024 - 05/2017
3	Laryngitis 11/2023 - 02/2009
3	Hypoxia (Hypoxemia) 11/2023 - 01/2021
3	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2023 - 11/2019
3	Obesity 01/2023 - 01/2020
3	Stomach Neoplasms (Stomach Cancer) 12/2022 - 10/2010
3	Carcinoma (Carcinomatosis) 08/2013 - 05/2003
2	Inflammation (Inflammations) 03/2024 - 08/2022
2	Pneumonia (Pneumonitis) 01/2024 - 10/2021
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2023 - 01/2022
2	Pain (Aches) 01/2023 - 03/2017
2	Sepsis (Septicemia) 12/2022 - 10/2022
2	Hemorrhage 12/2022 - 01/2022
2	Insulin Resistance 10/2022 - 01/2022
2	Adenocarcinoma of Lung 10/2022 - 01/2022
2	Hyperglycemia 01/2022 - 09/2015
2	Polyps 03/2021 - 11/2020
2	Hyperlipidemias (Hyperlipidemia) 04/2015 - 02/2010
2	Schistosomiasis (Bilharziasis) 08/2014 - 04/2014
2	Hypercholesterolemia 04/2013 - 04/2006
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 05/2009 - 10/2006
1	Dysbiosis 01/2024
1	Colitis 01/2024
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024
1	Bites and Stings (Sting) 01/2024
1	Diabetic Cardiomyopathies 12/2023
1	Dermatitis 11/2023
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Kaufman oculocerebrofacial syndrome 11/2023

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2006
13	Biomarkers (Surrogate Marker)IBA 11/2024 - 03/2008
12	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2011
9	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 10/2006
5	Phenobarbital (Luminal)FDA Link 04/2024 - 11/2018
5	CateninsIBA 12/2022 - 01/2019
5	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 01/2019
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2015
5	Pepsin A (Pepsin)IBA 03/2021 - 02/2009
4	Capsaicin (Zostrix)FDA Link 01/2023 - 03/2017
4	CholesterolIBA 01/2022 - 04/2013
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2013
4	Messenger RNA (mRNA)IBA 05/2017 - 04/2009
4	Hormones (Hormone)IBA 04/2015 - 04/2006
3	Tumor Biomarkers (Tumor Markers)IBA 11/2024 - 08/2013
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2023 - 10/2022
3	Ion Channels (Ion Channel)IBA 01/2023 - 11/2019
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 04/2009
3	Carbapenems (Carbapenem Antibiotics)IBA 12/2022 - 01/2018
3	cinobufotalinIBA 10/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
3	Epstein-Barr Virus Nuclear AntigensIBA 01/2020 - 08/2011
3	GoldIBA 08/2010 - 03/2008
3	Small Interfering RNA (siRNA)IBA 09/2006 - 03/2004
3	EndostatinsIBA 05/2006 - 06/2005
2	Immunologic Factors (Immunomodulators)IBA 01/2024 - 01/2020
2	InterferonsIBA 01/2024 - 05/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 12/2022
2	GlobinsIBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 01/2021
2	NucleotidesIBA 01/2023 - 01/2022
2	CationsIBA 01/2023 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 01/2022
2	Transient Receptor Potential ChannelsIBA 01/2022 - 11/2019
2	Therapeutic UsesIBA 10/2021 - 05/2017
2	CytokinesIBA 03/2020 - 01/2016
2	Endothelin-1 (Endothelin 1)IBA 06/2016 - 11/2014
2	alpha-2-HS-GlycoproteinIBA 01/2015 - 08/2013
2	LDL CholesterolIBA 06/2013 - 04/2013
2	Proton Pump InhibitorsIBA 05/2011 - 12/2010
2	Collagen Type IV (Type IV Collagen)IBA 04/2011 - 10/2010
2	Starch (Cornstarch)IBA 02/2009 - 04/2006
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024
1	Dextran SulfateIBA 01/2024
1	Dextrans (Dextran)FDA Link 01/2024
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2024
1	sanshoolIBA 01/2024
1	LipopolysaccharidesIBA 01/2024
1	didodecyldimethylammoniumIBA 01/2024
1	WD repeat containing planar cell polarity effectorIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023

Therapy/Procedure

22	Therapeutics 03/2024 - 05/2004
3	Radiotherapy 01/2024 - 04/2018
3	Drug Therapy (Chemotherapy) 11/2023 - 04/2018
3	Aftercare (After-Treatment) 01/2018 - 12/2013
2	Immunotherapy 01/2023 - 01/2022
2	Secondary Prevention 12/2022 - 01/2022
2	Induction Chemotherapy 05/2021 - 04/2018
2	Lasers (Laser) 01/2016 - 10/2008
2	Laparotomy 05/2009 - 04/2009